The global biomarkers market size is expected to reach USD 130.65 Billion in 2028 at a CAGR of 13.6% during the forecast period, according to latest report by Reports and Data.
The global biomarkers market size is expected to reach USD 130.65 Billion in 2028 at a CAGR of 13.6% during the forecast period, according to latest report by Reports and Data. Increasing use of biomarkers to establish safety and efficacy of drug therapeutics, growing knowledge regarding the importance of biomarkers in clinical diagnostics and prognostics, and rapid progress in personalized medicine are the key factors expected to drive market revenue growth over the forecast period. In addition, biomarkers can reduce costs associated with drug development process, enhance safety and efficacy of drugs and therapeutics, and accurately predict clinical outcomes. These are some other important factors expected to continue to fuel revenue growth of the market over the forecast period.
Biomarkers are biological substances or characteristics that provide an indication of biological state of organisms and can include physiological indicators, molecular markers, and imaging biomarkers. Biomarkers can offer indications of potential effectiveness and hazards associated with therapeutic interventions and are used to screen compounds for toxicity and efficacy before entering clinical trials. Biomarkers can help understand mechanism or biological pathway, or they can serve as a predictor of the course of disease and overall health.
Biomarkers have several potential roles in clinical research and practice, which include prognosis, prediction of response to therapies, as surrogate endpoints, in pharmacogenetics, and in monitoring patients during and after treatment, among others. Biomarkers can be detected in circulation or secretions and can be easily assessed non-invasively. Tissue-derived biomarkers can be assessed by biopsy or special imaging. Biomarkers are used to identify the likelihood of clinical events and probability of disease recurrence or progression in patients having chronic diseases. They are crucial in drug discovery and development, and this can further contribute to market revenue growth over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3706
Biomarkers are widely used in multiple clinical applications, such as screening for occult primary cancers, differentiating benign from malignant findings, determining prognosis and prediction for cancer patients, and monitoring progression of the disease. Biomarkers are also used in anti-cancer therapeutic development, and this is another key factor expected to drive market growth. However, difficulty in validation of biomarkers and high costs associated with biomarker testing are some key factors expected to hamper market growth to certain extent over the forecast period.
Some Key Highlights from the Report:
- The consumables segment is expected to account for largest revenue share between 2021 and 2028. The growth of this segment will be mainly driven by rising research activities to understand the clinical importance of biomarkers, increasing investments to develop robust research facilities and purchase high-quality consumables and reagents, and growing use of kits for biomarker testing.
- The efficacy biomarkers segment is expected to dominate other type segments in terms of revenue share over the forecast period, owing to increasing use of biomarkers to establish safety and efficacy profiles of therapeutics and rising application of efficacy-response biomarkers to predict clinical outcomes and patient responses to specific drugs, and as surrogates for clinical efficacy endpoints.
- Biomarkers play a crucial role in drug discovery and development as they can effectively predict the efficacy of drugs, patient outcomes, and determine benefit-risk profiles of drug therapeutics. They can also accelerate the development and availability of new therapeutics. All these factors are expected to contribute to revenue growth of the drug discovery and development segment.
- The infectious diseases segment is expected to account for significantly large revenue share, which can be attributed to increasing global prevalence of infectious diseases, rising use of biomarkers to detect infectious diseases, development of new and advanced biomarkers to distinguish between bacterial and viral infections, and advancements in proteomics technologies to detect protein biomarkers of infections.
- The Asia-Pacific market is expected to expand significantly over the forecast period, mainly due to increasing patient pool in APAC countries, rising investments to develop robust clinical and research facilities, increasing R&D on biomarkers and their importance in clinical diagnostics, and rapid advancements in drug development and discovery processes.
- Merck Millipore, Enzo Biochem, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Meso Scale Diagnostics, LLC, EKF Diagnostics Holdings, Inc., Biosims Technologies SAS, Signosis, Inc., Cisbio Bioassays, and Johnson & Johnson Services, Inc. are some major companies operating in the market.
- In November 2021, Radiomics and OncoDNA announced a strategic partnership to identify relevant cancer biomarkers for non-small cell lung cancer by combining Radiomics’ next-gen AI technology and OncoDNa’s expertise in characteriation of tumors.
To know more about the report @ https://www.reportsanddata.com/report-detail/biomarkers-market
For this report, Reports and Data has segmented the global biomarkers market on the basis of product, type, application, disease indication, and region:
Product Outlook (Revenue, USD Billion; 2018-2028)
- Consumables
- Software
- Services
Type Outlook (Revenue, USD Billion; 2018-2028)
- Efficacy Biomarkers
- Surrogate Biomarkers
- Predictive Biomarkers
- Prognostic Biomarkers
- Pharmacodynamic Biomarkers
- Safety Biomarkers
- Validation Biomarkers
Application Outlook (Revenue, USD Billion; 2018-2028)
- Drug Discovery and Development
- Diagnostic
- Disease Risk Assessment
- Personalized Medicine
- Others
Disease Indication Outlook (Revenue, USD Billion; 2018-2028)
- Cardiovascular Disease
- Cancer
- Immunological Disorders
- Infectious Diseases
- Neurological Disorders
- Other Diseases
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/3706
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/3706
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Laboratory Information Management Systems (LIMS) Market By Type, By Component (Software And Service), By Deployment, By Industry Vertical (Pharmaceutical & Biotechnology Industries, Bio-Banks & Bio-Repositories, Clinical Research Laboratories, Contract Service Organizations, Academic Research Institutes, Toxicology Laboratories, Oil & Gas Industry, Agriculture Industry, Environmental Testing Laboratories And Others), Forecasts To 2028
Anthrax Vaccines Market Share, Demand & Analysis, By Product Type (Cell-Free PA Vaccines and Live Vaccines), By Application (Human Use, Animal Use), By End-User, And Segment Forecasts, 2020-2028
Enteral Feeding Formulas Market Type (Standard Formula, Specialty Formula, Blenderized Formula), Form, Age (Adult and Infants), Application, Flavor - Global Forecast 2028
Surgical Devices Market By Device Type (Disposable Surgical Device, Reusable Surgical Device, Medical Robotics & Computer-assisted Devices), By Product, By Application, and By Region Forecast to 2028
Naloxone Spray Market By Dosage (2 mg/actuation and 4 mg/actuation), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, and Other) And Segment Forecasts, 2020-2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs